Cheque Drops (Mibolerone)
Active Substance: Cheque Drops
Description
What is Cheque Drops (Mibolerone)?
Cheque Drops is the brand name for the anabolic-androgenic steroid Mibolerone, also known by its chemical name 17α-dimethyl-19-nortestosterone. It is an extremely potent, orally active synthetic steroid that was originally developed as a veterinary drug to prevent estrus (heat) in female dogs. It is a derivative of nandrolone. Mibolerone is not approved for human use due to its high potential for toxicity, particularly to the liver.
The "DAC" mentioned in your query likely refers to a "Drug Affinity Complex" or similar technology that extends the half-life of a drug. However, there is no publicly available information or scientific literature that suggests Mibolerone is available in a form with DAC. The mention of DAC in this context is most likely a misconception or a reference to another drug entirely.
Side Effects and Benefits
Side Effects: Mibolerone is known for its extreme potency and severe side effects. The most significant concern is its high hepatotoxicity, meaning it is highly toxic to the liver. It can also cause:
-
Androgenic side effects: Mibolerone has a very high androgenic rating, leading to side effects such as acne, male-pattern baldness, and body hair growth. In women, it can cause virilization, including a deepened voice and clitoral enlargement, which may be irreversible.
-
Cardiovascular strain: Like many oral steroids, it can negatively impact cholesterol levels, increasing LDL (bad) cholesterol and decreasing HDL (good) cholesterol, leading to an increased risk of cardiovascular disease.
-
Progestogenic effects: Mibolerone has progestogenic activity, which can contribute to side effects like gynecomastia (male breast tissue enlargement) and other hormone-related issues.
-
Suppression of natural testosterone production: It will significantly suppress the body's natural production of testosterone.
Benefits: Due to its extreme potency, Mibolerone is used by some athletes and bodybuilders for a rapid increase in aggression and strength. However, its use is widely condemned due to the severe health risks involved. The "benefits" are limited and do not outweigh the potential for serious, permanent harm.
Pros and Cons
Pros:
-
Extreme potency: Mibolerone is one of the most potent steroids available, leading to a rapid and dramatic increase in strength and aggression.
-
Quick effects: Due to its oral nature and short half-life, its effects are felt very quickly.
Cons:
-
Extreme hepatotoxicity: This is the most significant con. The drug is known to be highly toxic to the liver, and even short-term use can cause significant damage.
-
Severe androgenic side effects: The high androgenic rating leads to a host of undesirable and potentially irreversible side effects.
-
Progestogenic activity: This can lead to gynecomastia and other hormonal imbalances.
-
Suppression of HPTA axis: It heavily suppresses the body's natural hormone production, requiring a thorough post-cycle therapy to restore function.
-
Not approved for human use: The drug has no approved medical use in humans, which means its safety and efficacy have not been established for this purpose.
Dosage and Frequency
Information on human dosage of Mibolerone is not widely available through official medical sources because it is not approved for human use. Based on anecdotal and black market information, doses are typically very low, often in the microgram range (e.g., 500-1000 mcg per day) and for very short periods, such as a week or two, often before an athletic competition. Due to its severe toxicity, using it for longer periods is highly dangerous.
Half-Life and Detection Time
-
Half-life: The half-life of Mibolerone is very short, estimated to be around 2-4 hours. This is why it needs to be taken daily or multiple times per day to maintain stable blood levels.
-
Detection time: Despite its short half-life, metabolites of Mibolerone can be detected in urine for a significant period. Detection times for most anabolic steroids vary depending on the individual's metabolism, dosage, and duration of use, but some sources suggest a detection window of up to several months.
Sterogenic, Progestronic, and Prolactin Effects
-
Sterogenic: Mibolerone is a synthetic anabolic-androgenic steroid. It binds to the androgen receptor with extremely high affinity, which is the primary mechanism for its powerful anabolic and androgenic effects.
-
Progestronic: Mibolerone has significant progestogenic activity. It can bind to the progesterone receptor, which can lead to side effects such as gynecomastia. This is particularly a risk when combined with aromatizable steroids.
-
Prolactin: Progestogenic steroids can increase prolactin levels, which can also contribute to gynecomastia and a range of other side effects, including sexual dysfunction.
Anabolic-Androgenic Ratio
The anabolic-androgenic ratio of a steroid compares its muscle-building (anabolic) properties to its masculinizing (androgenic) properties. This ratio is typically based on a comparison to testosterone, which has a ratio of 100:100.
Mibolerone is often cited as having an exceptionally high anabolic-androgenic ratio. While specific numbers can vary and are often based on anecdotal or animal studies rather than human trials, some sources state that Mibolerone's anabolic rating is over 4,000 and its androgenic rating is over 2,000. This would give it a ratio of approximately 4000:2000, or 2:1. However, these numbers are highly speculative and should be viewed with extreme caution, as they are not derived from clinical data in humans. The key takeaway is that Mibolerone is known for being both extremely anabolic and extremely androgenic, making it a very powerful and dangerous compound.
Pharmacological Properties
Half Life
3.8 hours
Active Dose
100%
Detection
0.80 days
Concentration
10 mg/tab
Anabolic/Androgenic Profile
Usage Effectiveness
Activity Profile
Estrogenic
None
Progestanic
None
Water Retention
None
Aromatization
No
Benefits
Dosage Recommendations
Beginner
20-40 mg/week
Intermediate
40-60 mg/week
Advanced
60-100 mg/week
Evidence-based planning resources
Dive deeper into Cheque Drops (Mibolerone) cycle design, stacking options, and harm-reduction checklists available inside Anabolic Planner.
- Cheque Drops (Mibolerone) compound database overviewCompare Cheque Drops (Mibolerone) with other steroid agents in the structured compound index.
- Cheque Drops (Mibolerone) stack and cycle templatesReview evidence-based cycle outlines, dose progressions, and PCT pairings that incorporate Cheque Drops (Mibolerone).
- Harm-reduction guide for Cheque Drops (Mibolerone)Refresh safety monitoring, lab work, and countermeasure strategies tailored for Cheque Drops (Mibolerone) protocols.
Peer-reviewed reference material
Validate mechanisms, contraindications, and regulatory guidance for Cheque Drops (Mibolerone) with trusted clinical databases.
- Cheque Drops clinical research on PubMedSearch peer-reviewed human and veterinary studies discussing efficacy, endocrine impact, and contraindications.
- Cheque Drops pharmacology via Drug Information PortalReview mechanisms, synonyms, regulatory status, and toxicology summaries from the U.S. National Library of Medicine.
Side Effects
Common
Severe
Safety Information
Liver Toxicity
Moderate
Kidney Toxicity
Low
Cardiovascular Risk
Moderate
Disclaimer: This information is for educational purposes only. Always consult with a qualified healthcare professional before using any compounds.